Amy Zuchelkowski, R.N.

Trauma-informed care (TIC) is essential to minimizing risks and maximizing growth during psychedelic therapy. Explore Sunstone’s patient-centered framework, where continuous informed consent, psychological safety, and individualized care are built into every step of the treatment process.

Sunstone Therapies is enrolling for SUN004, a Phase 2 study of psilocybin therapy for women with sexual assault-related PTSD. This trauma-informed trial utilizes a Shared Decision-Making framework to prioritize survivor agency and trust. Learn about our patient-led approach, which includes preparatory sessions, specialized therapeutic support, and optional long-term group integration.

Sunstone Therapies has launched a new clinical trial evaluating group MDMA-assisted therapy for veterans living with PTSD. Supported by funding from the State of Maryland and Reason for Hope, the study will compare individual and group therapy models to assess safety, feasibility, and scalability. The research aims to expand access to evidence-based mental health care for veterans while generating critical insights into how psychedelic-assisted therapy may be delivered more effectively in the future.